The National Yogurt Association (NYA) is creating a probiotics council – another signal the active cultures have achieved mainstream status in North America. NYA’s probiotic council will look to inform on industry standards and regulatory issues. The aim for its founders is for it to become the reference point for the probiotics industry in North America.
The concept of friendly bacteria has taken longer to catch on in the U.S. than in Europe, where it has long been a staple in the functional food market. However, thanks in large part to Danone’s Activia yogurt campaign, probiotics are making an increasing appearance in US dairy aisles and functional products beyond.
As such, yogurt manufacturers are feeling compelled to take an active role in probiotics and take part in any regulatory standards dialogue as it arises. While the specifics of the council have not been finalized, Martinez indicated it will draw primarily from industry food scientists who are members of NYA. However, the association does not want to limit dialogue to the yogurt industry.
On a global level, the International Probiotics Association (IPA), is looking to carry out a similar mandate. Founded in 2005, the Chicago-headquartered association wants to be become a network between researchers, academia and industry. IPA’s long term goal is to establish a certification program and third party testing based on standardized methodology surrounding probiotics.
3 Comments on “U.S. Yogurt Probiotic Council Formed”
Greetings,
I am a hospital pharmacist and interested in studying the effects of a yogurt, that contains specific combinations of probiotic-organisms, patients receiving antibiotic therapy.
A recent study found that consumption of a probiotic drink significantly decreased the occurrence of antibiotic-related diarrhea and C. difficile-related diarrhea in hospitalized patients receiving antibiotic therapy.
This information has major implications!!!
The cost to treat one case of C. difficile-related diarrhea hs been estimated to be $3,669 per patient in the U.S., primarily due to increased legnth of stay and the cost of vancomycin or other antibiotic.
I would like to reproduce a similar study in similar patients but with consumption of yogurt and would appreciate you help.
Unfortunately, I have no funds to conduct even a small trial, but I am seeking a yogurt supplier who might be interested in funding a small study. Would you be kind enough to reply with a number of companies who might be interested in this project?
As an alternative, you have my permission to forward this email to any yogurt company that you believe might be responsive to this request and who might get in touch with me directly.
Regards,
Elliot Freeman RPh
Staff Pharmacist
Our Lady of the Ressurrection Medical Center – Chgo
773-794-8482
Managing Editor
The Shared Newsletter
from Rx Communications
847-933-9498
Greetings,
I am a hospital pharmacist and interested in studying the effects of a yogurt, that contains specific combinations of probiotic-organisms, patients receiving antibiotic therapy.
A recent study found that consumption of a probiotic drink significantly decreased the occurrence of antibiotic-related diarrhea and C. difficile-related diarrhea in hospitalized patients receiving antibiotic therapy.
This information has major implications!!!
The cost to treat one case of C. difficile-related diarrhea hs been estimated to be $3,669 per patient in the U.S., primarily due to increased legnth of stay and the cost of vancomycin or other antibiotic.
I would like to reproduce a similar study in similar patients but with consumption of yogurt and would appreciate you help.
Unfortunately, I have no funds to conduct even a small trial, but I am seeking a yogurt supplier who might be interested in funding a small study. Would you be kind enough to reply with a number of companies who might be interested in this project?
As an alternative, you have my permission to forward this email to any yogurt company that you believe might be responsive to this request and who might get in touch with me directly.
Regards,
Elliot Freeman RPh
Staff Pharmacist
Our Lady of the Ressurrection Medical Center – Chgo
773-794-8482
Managing Editor
The Shared Newsletter
from Rx Communications
847-933-9498
Greetings,
I am a hospital pharmacist and interested in studying the effects of a yogurt, that contains specific combinations of probiotic-organisms, patients receiving antibiotic therapy.
A recent study found that consumption of a probiotic drink significantly decreased the occurrence of antibiotic-related diarrhea and C. difficile-related diarrhea in hospitalized patients receiving antibiotic therapy.
This information has major implications!!!
The cost to treat one case of C. difficile-related diarrhea hs been estimated to be $3,669 per patient in the U.S., primarily due to increased legnth of stay and the cost of vancomycin or other antibiotic.
I would like to reproduce a similar study in similar patients but with consumption of yogurt and would appreciate you help.
Unfortunately, I have no funds to conduct even a small trial, but I am seeking a yogurt supplier who might be interested in funding a small study. Would you be kind enough to reply with a number of companies who might be interested in this project?
As an alternative, you have my permission to forward this email to any yogurt company that you believe might be responsive to this request and who might get in touch with me directly.
Regards,
Elliot Freeman RPh
Staff Pharmacist
Our Lady of the Ressurrection Medical Center – Chgo
773-794-8482
Managing Editor
The Shared Newsletter
from Rx Communications
847-933-9498